Events

Upcoming Lectures

Autism genetics: Searching for coherence

Daniel Geschwind, M.D., Ph.D.Professor, University of California, Los Angeles

On 28 November, Daniel Geschwind will discuss his group's use of RNA sequencing, chromatin structure and gene networks to help develop an understanding of potential convergent mechanisms in autism spectrum disorders.

His talk is part of the Simons Foundation Autism Research lecture series.

Past Lectures

Understanding autism and other neurodevelopmental disorders: From the embryo to brain organoids

Paola Arlotta, Ph.D.Professor, Harvard University

On 1 November 2017, Paola Arlotta focused on the cerebral cortex and presented the challenges and opportunities of modeling human brain development using pluripotent stem cells within 3D human brain organoids. Building on developmental work in mice, such organoids promise a better understanding of complex neurodevelopmental conditions such as autism spectrum disorder.

Leveraging long-term health data and exome sequencing for autism-related gene discovery

David Ledbetter, Ph.D., FACMGExecutive Vice President & Chief Scientific Officer, Geisinger Health System

On 11 October 2017, David Ledbetter discussed the progress made by Geisinger Health System’s Precision Health Center – in partnership with Regeneron Genetics Center – towards advancing research and innovation by leveraging electronic health data and exome sequence data. Such an approach has already led to the successful identification of new drug targets and improved prevalence estimates of common Mendelian conditions, including familial hypercholesterolemia, BRCA-related cancers and Lynch syndrome, as well as autism spectrum and neuropsychiatric copy number variant disorders.

What can genetics tell us about autism spectrum disorder?

Stephan Sanders, B.M.B.S., Ph.D.Assistant Professor, University of California, San Francisco

On 22 March 2017, Stephan Sanders presented an update on the current state of genetics research in autism, highlighting some of the key findings that remain to be discovered, and discussing how these findings could ultimately benefit individuals with autism and their families.

Exploiting genetics to identify environmental risks for autism

Mark Zylka, Ph.D.Professor and Director, Neuroscience Center, University of North Carolina at Chapel Hill

On 22 February 2017, Mark Zylka described how candidate environmental risk factors for autism can be identified rationally, by pinpointing chemicals that interfere with the same molecular pathways that are affected in individuals with autism.

Subscribe to our newsletter and receive SFARI funding announcements and news